Variants of filamin C (FLNC) have been identified as rare genetic substrate for hypertrophic cardiomyopathy (HCM). Data on the clinical course of FLNC-related HCM are conflicting with some studies suggesting mild phenotypes whereas other studies have reported more severe outcomes. In this study, we present a novel FLNC variant (Ile1937Asn) that was identified in a large family of French-Canadian descent with excellent segregation data. FLNC-Ile1937Asn is a novel missense variant characterized by full penetrance and poor clinical outcomes. End stage heart failure requiring transplantation occurred in 43% and sudden cardiac death in 29% of affected family members. Other particular features of FLNC-Ile1937Asn include an early disease onset (mean age of 19 years) and the development of a marked atrial myopathy (severe biatrial dilatation with remodeling and multiple complex atrial arrhythmias) that was present in all gene carriers. The FLNC-Ile1937Asn variant is a novel, pathogenic mutation resulting in a severe form of HCM with full disease penetrance. The variant is associated with a high proportion of end-stage heart failure, heart transplantation, and disease-related mortality. Close follow-up and appropriate risk stratification of affected individuals at specialized heart centers is recommended.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/ajmg.a.63169 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Filamin C Truncating Variant Causes Severe Conduction Defects and Mild Cardiomyopathy.
Cureus
November 2024
Department of Medical Genetics, Institute of Science Tokyo, Tokyo, JPN.
Filamin C (FLNC), recently identified as a causative gene of cardiomyopathy, is widely expressed in cardiomyocytes and is involved in signal transduction between the sarcomere and the plasma membrane. In general, the FLNC truncating variant causes severe dilated cardiomyopathy. A 70-year-old female was referred to our hospital with advanced conduction defects and underwent pacemaker implantation.
View Article and Find Full Text PDFS6K/FLNC/ITGβ3 signaling pathway regulates osteoclastogenesis and the inhibition of osteoclastogenesis by columbianadin.
Phytomedicine
November 2024
Key Laboratory of Pharmacology of Traditional Chinese Medical Formulae, Ministry of Education, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, PR China; State Key Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, 10 Poyanghu Road, West Area, Tuanbo New Town, Jinghai District, Tianjin 301617, PR China. Electronic address:
Article Synopsis
- - The study investigates the effects of Columbianadin (CBN), a compound from traditional medicine, on inhibiting osteoclastogenesis, which contributes to bone loss, and seeks to identify its underlying mechanisms.
- - Researchers used transcriptomics, RT-PCR, Western blot analysis, and proteomics to uncover changes in gene expression during osteoclast differentiation, focusing on the S6K/FLNC/ITGβ3 signaling pathway.
- - Results showed that CBN significantly reduced FLNC levels, which in turn decreased markers of osteoclast differentiation and bone resorption in ovariectomized mice, suggesting CBN could be a therapeutic option for bone-related disorders.
Identification of a Missense Mutation in the Gene from a Chinese Family with Restrictive Cardiomyopathy.
J Multidiscip Healthc
November 2024
Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China.
Article Synopsis
- The study aimed to identify the genetic cause of restrictive cardiomyopathy (RCM) in a family using whole-exome sequencing (WES), highlighting the role of genetic variants in the disease's development.
- A 20-year-old male patient with severe heart failure symptoms was found to have a potentially harmful missense mutation in the filamin-C gene, which was absent in his healthy parents, suggesting it could be a new mutation.
- The discovery of this mutation, previously linked to hypertrophic cardiomyopathy, indicates a genetic overlap between different forms of cardiomyopathy, enhancing the understanding of RCM.
Protein phosphatase-1 regulates the binding of filamin C to FILIP1 in cultured skeletal muscle cells under mechanical stress.
Sci Rep
November 2024
Biochemistry II, Theodor-Boveri-Institut, Biozentrum, Faculty of Chemistry and Pharmacy, University of Würzburg, Würzburg, Germany.
The actin-binding protein filamin c (FLNc) is a key mediator in the response of skeletal muscle cells to mechanical stress. In addition to its function as a structural scaffold, FLNc acts as a signaling adaptor which is phosphorylated at S2234 in its mechanosensitive domain 20 (d20) through AKT. Here, we discovered a strong dephosphorylation of FLNc-pS2234 in cultured skeletal myotubes under acute mechanical stress, despite high AKT activity.
View Article and Find Full Text PDFNovel FLNC variants in pediatric cardiomyopathy: an insight into disease mechanisms.
Hum Genomics
October 2024
Pediatric Research Institute, Children's Hospital Affiliated to Shandong University (Jinan Children's Hospital), Jinan, China.
Background: FLNC gene variants have predominantly been reported in adult populations with cardiomyopathies, and early-onset cases are less common. The genotype-phenotype relationship indicates that dilated cardiomyopathy (DCM) is often associated with FLNC truncating variants.
Methods: We conducted a comprehensive genetic analysis using next generation sequencing (NGS) to identify FLNC variants in patients with cardiovascular conditions.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!